Virtu Financial’s PDL BioPharma, Inc. PDLI Stock Holding History

Virtu Financial’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-21,796	Closed	-$47K	–	2083
2019 Q3	$47K	Buy	+21,796	New	+$58.3K	﹤0.01%	1204
2018 Q4	–	Sell	-32,213	Closed	-$85K	–	2250
2018 Q3	$85K	Buy	32,213 +19,141	+146%	+$47K	0.01%	1226
2018 Q2	$31K	Buy	+13,072	New	+$36.5K	﹤0.01%	1825
2018 Q1	–	Sell	-11,114	Closed	-$30K	–	3100
2017 Q4	$30K	Sell	11,114 -32,320	-74%	-$99.3K	﹤0.01%	2163
2017 Q3	$147K	Buy	+43,434	New	+$121K	0.01%	1974
2015 Q3	–	Sell	-34,355	Closed	-$221K	–	442
2015 Q2	$221K	Buy	+34,355	New	+$230K	0.02%	284

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ECM

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial's PDLI Position: Q4 2019 in Review

Virtu Financial sold out of PDL BioPharma, Inc. (PDLI) in Q4 2019, closing a stake of 21,796 shares — an estimated $47K sold.

Virtu Financial first reported a position in PDLI in Q2 2015 and held it in 6 quarters. The position peaked at $221K in Q2 2015. 150 funds tracked by Wall St. Rank hold PDLI as of Q4 2019.

Virtu Financial reported no remaining PDL BioPharma, Inc. position as of Q4 2019 after selling out during the quarter.
Virtu Financial sold 21,796 PDL BioPharma, Inc. shares in Q4 2019, an estimated $47K.
Virtu Financial first reported a position in PDL BioPharma, Inc. in Q2 2015 and held it in 6 quarters.
Virtu Financial's PDL BioPharma, Inc. position peaked at $221K in Q2 2015.
150 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2019.

Based on Virtu Financial's 13F filing for Q4 2019, filed 4 Feb 2020.